T cells in organ ischemia reperfusion injury.
T cells in organ ischemia reperfusion injury.
复制标题
DOI:
10.1097/mot.0000000000000064
复制
发表时间:
2014-04
影响因子:
2.2
通讯作者:
Zhai Y
中科院分区:
文献类型:
--
作者:
Rao J;Lu L;Zhai Y
Ischemia and reperfusion injuries occur in multiple clinical settings and contribute to organ dysfunction/failures. Despite the innate inflammatory immune nature, T cells are critically involved in the pathogenesis of IRI, which includes not only CD4+ T cells, but also CD8+ and γδ T cells. This review focuses on questions of how putative Ag-specific T cells are involved, which include whether they function in Ag-dependent manner; how they function, cytokine- or costimulatory molecule-mediated mechanisms; and whether different T cell subsets, Th1, Th17, Treg, are all involved and play distinctive roles? Specific T cell populations, such as effector memory CD4 T cells, promote inflammatory immune activation by IR independent of their adaptive properties, i.e., Ag-independent. They function by secreting cytokines and expressing costimulatory molecules to either promote or inhibit innate immune activation or facilitate tissue repair/homeostasis, as exemplified by Th1, Th17 or Th2, Treg cells respectively. T cell targeted therapies need to be refined with strategies to maximally eliminate the pro-inflammatory but spare the anti-inflammatory/immune regulatory properties of T cells, for future clinical application to ameliorate IRI.